HIV Vaccine Info-line
080 VACCINE

 

HAVEG publications

Articles in peer-reviewed journals

Book chapters

  • Stobie, M.L., Strode, A., & Slack, C. (2005) The dilemma of enrolling children in HIV vaccine research in South Africa:  What is in a child’s best interest? In A.A. Van Niekerk, & L.M. Kopelman, L.M. (Eds) AIDS in Africa pp 190-207.Cape Town: David Philip/New Africa Books.
  • Wassenaar, D., & IJsselmuiden, C. (2007). Commentary: Obligations to participants harmed in the course of the N-9 multi-center vaginal microbicide trial in South Africa: Was the N-9 trial ethical? Questions and lessons. In J,V. Lavery, E. Wahl, C. Grady, & E.J. Emanuel. (Eds). Ethical issues in international biomedical research: A case book pp. 319-325. New York: Oxford University Press.
  • Slack, C., Stobie, M., & Barsdorf, N. (2007). Access to treatment for trial participants who become infected with HIV during the course of Phase 1 trials of a preventive HIV vaccine in South Africa: The limits of obligations to provide treatment in the South African Phase 1 HIV vaccine trials. In J,V. Lavery, E. Wahl, C. Grady, & E.J. Emanuel. (Eds). Ethical issues in international biomedical research: A case book pp. 219-225. New York: Oxford University Press.
  • Stobie, M.L., Strode, A., & Slack, C. (In Press). The dilemma of enrolling children in HIV vaccine research in South Africa: What is in a child's best interest?. In A. A. Van Niekerk, & L.M. Kopelman, (Eds). AIDS in Africa. Cape Town: David Philip/New Africa Books.
  • Lindegger, G. (2005). Informed consent in HIV Vaccine trials. In Kahn, P. (Ed) AIDS vaccine handbook: Global perspectives, (2nd ed.) pp. 109 - 116. New York: AIDS Vaccine Advocacy Coalition (AVAC).

Reports & Lay publications

  • Wassenaar, D.R., Barsdorf, N.W., and Richter, L.M. (2005). Gender and HIV vaccine trials: Ethics and Social science issues. Harvard Health Policy Review (in press).
  • Van Loon, K., Lindegger G., and Slack C. (2002). Informed consent: The experiences of clinical trial researchers in South Africa. 14th International AIDS Conference Proceedings. Monduzzi AIDS 2002 publication.
  • Lindegger, G. & Bull, S (2002). Ensuring valid consent in a developing country context. http://www.scidev.net/dossiers/ethics/erpolicy_lindegger_bull.html
  • Richter, L (2001). Response to Nuffield Foundation's Public Consultation on the Ethics of Health-Care related Research in Developing Countries.
  • Lindegger, G. (2000). Cross cultural issues in the implementation of informed consent in HIV vaccine trials. XIII International AIDS Conference Proceedings. Monduzzi AIDS 2000 publication.
  • Lindegger, G. & Slack, C. (2002). Making sure HIV vaccine clinical trials are ethically sound and culturally sensitive: A brief report on the HIV AIDS Vaccines Ethics Group. AIDS Bulletin, July, 19-20. Medical Research Council.
  • Slack, C, Lindegger, G, Wassenaar, D (2002). The ethical issues in clinical trials. Newletter: Lawyers for Human Rights: Yands'ulwazi; July , 3-5.
  • Wassenaar, D.R, and Richter, L.M (2000). Women at the centre of the relationship between science and ethics in HIV/ AIDS vaccine trials in developing countries. AIDS Legal Quarterly, December, 6-7.
  • Slack, C (2000). Knowing and doing the right things: Ethical issues in HIV AIDS vaccine trials. AIDS Legal Quarterly, December, 11.
  • HAVEG (2001). Ethical issues in HIV vaccine trials. Department of Health HIV AIDS and TB newsletter.
  • Strode, A., Slack,. C., Singh, J., Grant., & Stobie, M. (2006). Regulating AIDS-related research with children: A South African perspective. Asia-Pacific Biotech News 10(11), 588-590.

Presentations at conferences and capacity building workshops

  • Slack, C., Essack., Z., & Strode. A. (2008). Ethical-legal issues in adolescent HIV vaccine and microbicide trials: Report on an international consultation. Paper presented at the Microbicides 2008 conference, New Delhi, India, 26th February, 2008.
  • Essack, Z., Slack, C., & Strode, A. (2007). Adolescents in HIV vaccine and microbicide trials: An overview of ethical challenges identified in the literature. Paper presented at the 4th AAVP Forum, Abuja, Nigeria, 28-30 November 2007.
  • Essack, Z., Slack, C., & Strode, A. (2007). Adolescents in HIV vaccine and microbicide trials: An overview of ethical challenges identified in the literature. Paper presented at the GCM/PATH sponsored meeting on adolescents in HIV vaccine and microbicide trials, Durban, South Africa, 5-6 September 2007.
  • Strode, A., Slack, C., Wassenaar, D., & Singh, J. (2007). One step forward, two steps back: Requiring ministerial approval for all “non-therapeutic” health research with minors. Oral presentation at the 3rd SA AIDS Conference, Durban, South Africa, 5-8 June 2007.
  • Lindegger, G., Milford, C., Slack, C.M., Quayle, M., Xaba, X., & Vardas, E. (2007). Beyond the checklist: Assessing understanding for HIV vaccine trial participation in South Africa. Paper presented at the satellite session on socio-behavioural issues in HIV vaccine research at the 3rd SA AIDS Conference, Durban, South Africa, 5-8 June 2007.
  • Koen, J., Barsdorf, N., Slack, C., & Mukuka, R (2007). A review of models and practices for payment of participants in research, with recommendations for South Africa. Poster presented at the 3rd SA AIDS Conference, Durban, South Africa, 5-8 June 2007.
  • Ranchod, C., Slack, C., Lindegger, G., Essack, Z., & Xaba, X. (2007). Assessing children’s understanding for consent to research: Complying with ethical standards and impending South African law. Paper presented at the 3rd South African AIDS conference. Durban, South Africa. 5-8 June 2007.
  • Toohey, J., Strode, A., & Slack, C. (2007). Legal obligations on researchers to report maltreatment, abuse and neglect of children: Implications and complexities. Poster presented at the 3rd SA AIDS Conference, Durban, South Africa, 5-8 June 2007.
  • Lindegger, G., Milford, C., Slack, C.M., Quayle, M., Xaba, X., & Vardas, E. (2007). Beyond the checklist: Assessing understanding for HIV vaccine trial participation in South Africa. Paper presented at the HVTN conference, Washington, 1-4 May 2007.
  • Slack, C., Strode, A., Lindegger, G., & Xaba, X. (2006). Ethics research into children and consent: Some South African reflections. Paper presented at the International Seminar: HIV vaccine research: Ethical and regulatory issues, Brasilia, Brazil, 4-5October 2006.
  • Milford, C., Barsdorf, N., & Lindegger, G. (2006). Payment for HIV vaccine research participation: South African stakeholders' perceptions. Poster at the AIDS Vaccine 2006 Conference, Amsterdam, Netherlands, 29 August - 1 September.
  • Milford, C., Slack, C., & Strode, A. (2006). What do stakeholders in South Africa view as major ethical challenges in adolescent HIV vaccine trials? Poster at the AIDS Vaccine 2006 Conference, Amsterdam, Netherlands, 29 August - 1 September.
  • Milford, C., Barsdorf, N., Slack, C., Strode, A., & Xaba, X. (2006). Social harms in HIV vaccine trials: Perceptions of South African stakeholders. Poster at the XVI International AIDS Conference, Toronto, Canada, 13-18 August.
  • Ranchod, C., Lindegger, G., Milford, C., Burnard, A., & Slack, C. (2006). Informed consent in HIV vaccine trials in South Africa: Perceptions of stakeholders. Presentation at the 8th World Congress of Bioethics, Beijing, China, 6-9 August.
  • Stobie, M.L. (2006). The participation of children in HIV vaccine trials: An ethical analysis. Paper presented at the Society For Applied Philosophy Conference, Manchester, 30 June to 2 July
  • Strode, A., & Slack, C. (2006). Enrolling adolescents in HIV vaccine trials: an ethical-legal analysis. Paper presented at the HVTN meeting, Bethesda, Maryland, 23 May, 2006.
  • Stobie, M., & Slack, C. (2006). Beyond morally praise-worthy: Beneficence and ART access for prevention trial participants. Invited paper presented at the International Microbicides Conference, 23rd-26th April 2006, Cape Town.
  • Strode, A., Slack. C, Ngwenya, N., & Morar, N. (2006). What makes adolescent microbicide trials lawful? Paper presented at the International Microbicides Conference, Cape Town, 23-26 April 2006.
  • Stobie, M. (2005). Social and ethical aspects of vaccine and drug delivery” A Time to Heal: Cracking Africa's Killer Diseases. Africa Genome Education Institute. Nairobi, Kenya, 21-24 March.
  • Stobie, M., Slack, C., Milford, C., Lindegger, G., Wassenaar, D., Strode, A., & IJsselmuiden, C. (2005). Provision of HIV treatment in HIV vaccine trials: An ethical analysis Paper presented at WHO Institute for Vaccine Research consultation on Ethical Considerations related to the Provision of care and Treatment in vaccine Trials. Zomba, Malawi, 15-16 March.
  • Slack, C. (2005). Ancillary care. Paper presented in special session on ancillary care. Paper presented at EU/University of Bergen & SARETI Conference on Ethical Aspects of Clinical Research in Developing Countries. Umhlanga Rocks, Durban, 28 February - 2 March .
  • Wassenaar, D., & Slack, C. (2004). Access to treatment in HIV vaccine trials: The South African case. Presented at First NIH/AMANET Advanced Course in research Ethics, Zanzibar, 1-3 December.
  • Lindegger, G., Van Loon, K., Maxwell, J., Slack, C., & Milford, C. (2004). Experiences of informed consent in a culturally diverse context. Paper presented at the 7 th World Congress of Bioethics, University of New South Wales, Sydney, Australia, 9-12 November.
  • Lindegger, G., Milford, C., & Slack, C. (2004). The development and comparison of methods to assess understanding for informed consent for phase I HIV vaccine trials. Paper presented at the 7 th World Congress of Bioethics, University of New South Wales, Sydney, Australia, 9-12 November 2004.
  • Stobie, M., & Lindegger, G. (2004). Children's capacity for altruistic choices: Implications for the enrollment of children in HIV vaccine trials. Paper presented at the 7 th World Congress of Bioethics, University of New South Wales, Sydney, Australia, 9-12 November 2004.
  • Milford, C., Lindegger, G., & Slack, C. (2004). Developing tools to “test “ understanding in HIV vaccine trials in South Africa . Poster at the XV International AIDS Conference, Bangkok Thailand 11-16 July.
  • Strode, A., & Slack, C. (2004). Ethical-legal complexities in adolescent participation in HIV vaccine trials. A South Africa case study. Paper presented at the XV International AIDS Conference, Bangkok, Thailand, 11-16 July.
  • Slack, C., Strode, A., & Kruger, M. (2004). Developing guidelines for the South African Medical Research Council on HIV vaccine research. Paper presented at the Nuffield Council on Bioethics workshop on the ethics of research related to health-care in developing countries, Cape Town, 12-14 February.
  • Stobie, M. (2004). Enrolling children in HIV vaccine trials: Balancing justice and beneficence. Paper presented at the Philosophical Society of South Africa Conference, Fernhill, KwaZulu-Natal, 19 January.
  • Stobie, M., Slack, C., & Barsdorf, N. (2004). Access to treatment for HIV infection for phase I HIV vaccine trial participants: Obligations in a non-ideal world. Paper presented at the Ethics Society of South Africa's Inaugural conference, Johannesburg, 29 March.
  • Slack, C., Stobie, M., Lindegger, G., Milford, C., Wassenaar, D., Strode, A., & IJsselmuiden, C. (2003). Access to treatment for participants who become infected during the course of an HIV vaccine trial. Paper presented at the NIH Third Bioethics Conference in Africa, Kampala, Uganda, 21 March.
  • Slack, C., Stobie, M., Lindegger, G., Milford, C., Wassenaar, D., Strode, A., & IJsselmuiden, C. (2003). Ethical considerations in HIV vaccine trials in South Africa: A focus on standard of care . Paper presented at the 23 rd International Congress of Chemotherapy, Durban, South Africa, 7-9 June.
  • Strode, A., Slack, C., Milford, C., & Stobie, M. (2003). A critical evaluation of South Africa's ethical-legal framework. Paper presented at the First South African AIDS Conference, Durban, South Africa, 3-6 August.
  • Milford , C., Wassenaar, D.R., Slack, C., Strode, A., & Khan, N (2003). Identifying resources and needs of research ethics committees in Africa in preparation for HIV vaccine trials. Paper presented at First South African AIDS Conference, Durban, South Africa, 3-6 August.
  • Slack, C., Stobie, M., Lindegger, G., Milford, C., Wassenaar, D., Strode, A., & IJsselmuiden, C. (2003). Standard of care in international trials of HIV vaccines and Microbicides. Paper presented at the International Consultation on ethical issues in the clinical testing of Microbicides, 23-24 October.
  • IJsselmuiden, C. (2003). International research ethics and key debates. Paper presented at the International Consultation on ethical issues in the clinical testing of Microbicides, 23-24 October.
  • Slack, C., Stobie, M., Lindegger, G., Milford, C., Wassenaar, D., Strode, A., & IJsselmuiden, C. (2003). Access to treatment in HIV vaccine trials. Paper presented at the WHO-UNAIDS consultation on modalities for treatment for trial participants who become infected during HIV prevention trials, Geneva, Switzerland, 17-18 July.
  • Lindegger, G., & Slack, C. (2003). Culture and informed consent: Implications for HIV vaccine trials. Paper presented at the Full Group Meeting of the HIV Vaccine Trials Network (HVTN), Bethesda, Maryland, USA, 19-21 May.
  • Milford , C., Wassenaar, D.R., Slack, C. Strode, A., Khan, N. (2003). Identifying resources and needs of research ethics committees in Africa in preparation for HIV vaccine trials. Paper presented at the Capacity Building Workshop for African Resource Persons and Regional Ethics Committee Members involved in Ethical Review, Kampala, Uganda, 17-18 March.
  • Milford , C., Wassenaar, D.R., Slack, C., Khan, N. (2003). Resources and capacity building needs of research ethics committees in Africa in preparation for HIV vaccine trials. Paper presented at the Second Annual Meeting of African AIDS Vaccine Programme (AAVP): Strategies for the development of HIV vaccine trial sites in Africa: Challenges and Opportunities, Addis Ababa, Ethiopia. 16-18 June.
  • Slack, C., Stobie, M., Lindegger, G., Milford, C., Wassenaar, D., Strode, A., & IJsselmuiden, C. (2003). Standard of care in HIV preventive vaccine trials. Paper presented at t he Second Annual Meeting of African AIDS Vaccine Programme (AAVP): Strategies for the development of HIV vaccine trial sites in Africa: Challenges and Opportunities, Addis Ababa, Ethiopia. 16-18 June.
  • Wassenaar, D., & Richter, L., (2002). Women at the centre of the relationship between science and ethics in HIV/AIDS vaccine trials in developing countries. Keynote address at the Third Global Forum for Bioethics, Cape Town, February.
  • Lindegger, G., Richter, L., Slack, C., & Wassenaar, D., (2002). Cultural considerations in clinical trials. Paper presented at the Third Global Forum for Bioethics, Cape Town, February.
  • Lindegger, G., Slack, C., Richter, L. & Wassenaar, D, (2002). Ethical issues in HIV vaccine trials. Paper presented at the Clinical Trials in Africa conference, Johannesburg, April.
  • Van Loon, K,, Lindegger, G., & Slack, C., (2002). Informed consent: A review of South African clinical trial researchers' experiences . Paper presented at the 14 th International AIDS Conference, Barcelona, July.
  • Lindegger, G. Richter, L., Slack, C., & Wassenaar, D. (2001). Cultural considerations in clinical trials. Paper presented at the Revised Declaration of Helsinki conference, World Medical Association, Pretoria, South Africa, 27 - 28 March.
  • Lindegger, G., Slack, C., Richter, L., & Wassenaar, D. (2001). Ethical issues in recruitment of participants for clinical trials. Paper presented at the DIA Clinical trials in Africa conference, Johannesburg, 10 - 12 April.

SAAVI is supported by

Impala
Home • Partners • FAQs • Getting involved • Resources • Press releases • Useful links • Contact us • Disclaimer
Last updated: 22-Oct-2008